Christopher Rork
Insider
First SEC filing: May 16, 2011 · Latest: May 16, 2011
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| May 12, 2014 | CRI | M | 2,000 | · | · | 6,000 Direct | +50.00% | Acquired | (price as of 2026-10-02) |
| May 12, 2014 | CRI | M | 7,500 | · | · | 15,000 Direct | +100.00% | Acquired | (price as of 2026-10-02) |
| May 12, 2014 | CRI | S | 2,000 | $74.06 | $148,120 | 38,722 Direct | -4.91% | Disposed | -57.3% (price as of 2026-10-02) |
| May 12, 2014 | CRI | M | 2,000 | $42.61 | $85,220 | 40,722 Direct | +5.17% | Acquired | -25.9% (price as of 2026-10-02) |
| May 12, 2014 | CRI | S | 7,500 | $74.06 | $555,450 | 38,722 Direct | -16.23% | Disposed | -57.3% (price as of 2026-10-02) |
| May 12, 2014 | CRI | M | 7,500 | $30.18 | $226,350 | 46,222 Direct | +19.37% | Acquired | 4.7% (price as of 2026-10-02) |
| May 12, 2014 | CRI | F | 1,438 | $74.06 | $106,498 | 38,722 Direct | -3.58% | Disposed | -57.3% (price as of 2026-10-02) |
| Feb. 22, 2014 | CRI | F | 383 | $67.89 | $26,002 | 40,610 Direct | -0.93% | Disposed | -53.5% (price as of 2026-10-02) |
| Feb. 20, 2014 | CRI | F | 383 | $66.83 | $25,596 | 40,993 Direct | -0.93% | Disposed | -52.7% (price as of 2026-10-02) |
| Feb. 18, 2014 | CRI | A | 3,800 | · | · | 3,800 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 18, 2014 | CRI | A | 3,800 | · | · | 41,376 Direct | +10.11% | Acquired | (price as of 2026-10-02) |
| Feb. 18, 2014 | CRI | A | 1,900 | · | · | 37,576 Direct | +5.33% | Acquired | (price as of 2026-10-02) |
| May 14, 2013 | CRI | M | 7,500 | · | · | 22,500 Direct | +50.00% | Acquired | (price as of 2026-10-02) |
| May 14, 2013 | CRI | S | 7,500 | $70.03 | $525,225 | 35,676 Direct | -17.37% | Disposed | -54.9% (price as of 2026-10-02) |
| May 14, 2013 | CRI | M | 7,500 | $30.18 | $226,350 | 43,176 Direct | +21.02% | Acquired | 4.7% (price as of 2026-10-02) |
| May 12, 2013 | CRI | F | 1,250 | $69.79 | $87,238 | 35,676 Direct | -3.39% | Disposed | -54.7% (price as of 2026-10-02) |
| Feb. 22, 2013 | CRI | F | 483 | $58.41 | $28,212 | 36,926 Direct | -1.29% | Disposed | -45.9% (price as of 2026-10-02) |
| Feb. 20, 2013 | CRI | A | 8,000 | · | · | 8,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 20, 2013 | CRI | A | 8,000 | · | · | 37,409 Direct | +27.20% | Acquired | (price as of 2026-10-02) |
| Feb. 20, 2013 | CRI | A | 4,000 | · | · | 29,409 Direct | +15.74% | Acquired | (price as of 2026-10-02) |
| May 12, 2012 | CRI | F | 1,591 | $50.74 | $80,727 | 25,409 Direct | -5.89% | Disposed | -37.7% (price as of 2026-10-02) |
| Feb. 22, 2012 | CRI | A | 8,000 | · | · | 8,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 22, 2012 | CRI | A | 8,000 | · | · | 27,000 Direct | +42.11% | Acquired | (price as of 2026-10-02) |
| Feb. 22, 2012 | CRI | A | 4,000 | · | · | 19,000 Direct | +26.67% | Acquired | (price as of 2026-10-02) |
| May 12, 2011 | CRI | A | 30,000 | · | · | 30,000 Direct | · | Acquired | (price as of 2026-10-02) |
| May 12, 2011 | CRI | A | 15,000 | · | · | 15,000 Direct | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| May 12, 2014 | CRI | Employee Stock Option (Right to Purchase) | Common Stock | $74.06 | Feb. 22, 2022 | 2,000 | Acquired |
| May 12, 2014 | CRI | Employee Stock Option (Right to Purchase) | Common Stock | $74.06 | May 12, 2021 | 7,500 | Acquired |
| Feb. 18, 2014 | CRI | Employee Stock Option (Right to Purchase) | Common Stock | $68.49 | Feb. 18, 2024 | 3,800 | Acquired |
| May 14, 2013 | CRI | Employee Stock Option (Right to Purchase) | Common Stock | $30.18 | May 12, 2021 | 7,500 | Acquired |
| Feb. 20, 2013 | CRI | Employee Stock Option (Right to Purchase) | Common Stock | $59.27 | Feb. 20, 2023 | 8,000 | Acquired |
| Feb. 22, 2012 | CRI | Employee Stock Option (Right to Purchase) | Common Stock | $42.61 | Feb. 22, 2022 | 8,000 | Acquired |
| May 12, 2011 | CRI | Employee Stock Option (Right to Purchase) | Common Stock | $30.18 | May 12, 2021 | 30,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| May 16, 2011 | CRI | No securities beneficially owned. | 0 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2011 | $294,231 | · | $452,700 | $375,000 | $253,150 | · | $108,972 | $1,584,053 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.